SpectraBase Spectrum ID |
2mMW9mRsL1k |
Name |
Butallylonal 2ME |
Classification |
Pharmaceutical drug derivative |
Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
DEA Citation |
21 CFR §1308.13 (c) (3) |
DEA Controlled Substance Form |
Any compound, mixture or preparation |
DEA Controlled Substance Name |
Barbituric acid derivatives |
DEA Controlled Substance Type |
Salts, isomers, derivatives and salts of isomers and derivatives |
DEA Controlled Substances Code Number |
2100 |
DEA Schedule |
Schedule III |
DEA Section |
Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system |
Exact Mass |
330.057905477 u |
Formula |
C13H19BrN2O3 |
InChI |
InChI=1S/C13H19BrN2O3/c1-6-8(2)13(7-9(3)14)10(17)15(4)12(19)16(5)11(13)18/h8H,3,6-7H2,1-2,4-5H3 |
InChIKey |
GOCNAOAYIZROIY-UHFFFAOYSA-N |
Ionization Type |
Electron Ionization (EI) |
Molecular Weight |
331.210 g/mol |
Nominal Mass |
330 u |
Quality |
998 |
Retention Index |
1825 |
SMILES |
C1(C(N(C(N(C1=O)C)=O)C)=O)(C(CC)C)CC(Br)=C |
SPLASH |
splash10-0002-3930000000-ad7f9a3c36a5db85b37e |
Source of Spectrum |
DigiLab GmbH (C) 2024 |
Synonyms |
5-(2-bromoprop-2-en-1-yl)-5-(butan-2-yl)-1,3-dimethyl-1,3-diazinane-2,4,6-trione |
Technique |
GC/MS |
Wiley ID |
DD2024_011674 |